| 摘要 |
<p>The use of a therapeutically effective amount of a pyrrolidinacetamide analogue, such as POPOA, for treating dopamine realated neuropyschiatric disorders such as schizophrenia, autism spectrum disorder (ASD), bipolar disorder, Alzeimer's disease, Lewy body disease and drug or behavioral addications.</p> |
| 申请人 |
MCMASTER UNIVERSITY;JOHNSON, RODNEY;MISHRA, RAM, K.;DYCK, BAILEY;BASU, DIPANNITA;BEYAERT, MICHAEL |
发明人 |
JOHNSON, RODNEY;MISHRA, RAM, K.;DYCK, BAILEY;BASU, DIPANNITA;BEYAERT, MICHAEL |
